Forbes

As Fluoride regulations are being discussed across the nation, a dentist weighs in on steps parents can take to protect their children's teeth at home.

Do social media algorithms harm kids’ brains? A doctor explains how platforms shape attention, emotions and development, and what parents can do to protect children.

There's mounting evidence that more prospective students are considering what mental health and support services are available on campus while selecting a college.

Your defended weight range can gradually shift upward through hormonal, metabolic, environmental, and microbiome-driven changes that push the body toward higher weight.

A study found that Trump administration NIH grant cuts led to termination of 118 trials studying cancer, 97 studying infectious diseases and 140 testing new treatments.

AI predictions are set to become part of end-of-life care decisions, but what role they’ll play in relation to humans and our values remains a wide-open question.

Will Elon Musk's Tesla robot be able to perform surgery? What does this mean for patients? And, how are surgeons currently using robots in surgery?

The end of the shutdown offers a chance for policymakers and industry leaders to confront a larger question: What kind of healthcare system are we trying to sustain?

Abbott Laboratories $21 billion deal to acquire cancer test maker Exact Sciences could bolster the company’s diagnostic division that has lost sales from COVID tests.

A mutated strain of Influenza H3N2 virus known as subclade K is spreading in the United States. A doctor breaks down what to know and how to stay safe.

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more.

As America’s population ages, immigrants will play a significant role in providing health care to Americans, according to new research.

ADHD benefits help many high-achieving doctors excel. See how neurodivergent strengths like hyperfocus and pattern recognition shape better care.

Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.